EBS Financial Facts
Contracts and grants: 31.5MTotal revenues: 142.91M
See Full Income Statement
Deferred tax assets, net: 11.29M
Inventories: 81.16M
See Full Balance Sheet
Emergent BioSolutions, Inc. (EBS) Earnings
|
Expand Research on EBS
Next EPS Date | 4/25/24 | EPS Growth Rate | +99.1% |
---|---|---|---|
Average EPS % Beat Rate | -421.0% | Revenue Growth Rate | +12.3% |
Average % Move 1-Wk after EPS | -23.2% | Normal Earnings Time | After Close |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
4/25/24 | Q124 | N/A | -$0.03 | N/A | N/A | $185.4M | N/A | N/A | N/A | ||
2/26/24 | Q423 | N/A | $0.16 | N/A | N/A | $282.16M | = | N/A | N/A | ||
2/22/24 | Q423 | N/A | $0.16 | N/A | N/A | $282.16M | = | N/A | N/A | ||
3/6/24 | Q423 | N/A | $0.16 | N/A | N/A | $282.16M | = | N/A | N/A | ||
11/2/23 | Q323 | N/A | -$0.28 | N/A | N/A | $237.43M | = | N/A | N/A | ||
11/8/23 | Q323 | N/A | $0.00 | N/A | $271M | $237.43M | = | N/A | N/A | ||
7/27/23 | Q223 | N/A | -$0.69 | N/A | N/A | $216.2M | = | N/A | N/A | ||
8/8/23 | Q223 | -$1.06 | -$0.63 | -$0.43 | $337.9M | $217.03M | = | Details |